Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030346704> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2030346704 endingPage "21" @default.
- W2030346704 startingPage "118" @default.
- W2030346704 abstract "The feasibility of adjuvant cisplatin, methotrexate and vinblastine chemotherapy was evaluated in Taiwanese patients with invasive transitional cell carcinoma at high risk for recurrence.We assigned 56 patients with high risk transitional cell carcinoma (vascular or lymphatic invasion in the primary tumor, poorly differentiated stage P2, P3, P4 or N+ and M0) to receive adjuvant chemotherapy after radical urological surgery. The chemotherapy consisted of 40 mg./m.2 methotrexate and 4 mg./m.2 vinblastine on days 1 and 8, and 100 mg./m.2 cisplatin on day 2 given in 6 courses at 21-day intervals.Median followup was 44 months. An average of 4.63 cycles of chemotherapy was administered. The median actual survival was 44 months, and the 1 and 3-year survival probabilities were 92% and 50%, respectively. The median disease-free survival was 15.5 months, and the 1 and 3-year disease-free survival probabilities were 66% and 28%, respectively. Only 5 (9%) and 1 (2%) patients had grades 3 and 4 leukopenia, respectively, and none died of sepsis.The use of adjuvant cisplatin, methotrexate and vinblastine chemotherapy in patients with invasive transitional cell carcinoma at high risk for recurrence is feasible with tolerable toxicity but randomized controlled trials will be required to assess the benefit." @default.
- W2030346704 created "2016-06-24" @default.
- W2030346704 creator A5015263316 @default.
- W2030346704 creator A5025595895 @default.
- W2030346704 creator A5026192090 @default.
- W2030346704 creator A5042834618 @default.
- W2030346704 creator A5054874627 @default.
- W2030346704 creator A5072244858 @default.
- W2030346704 date "1996-01-01" @default.
- W2030346704 modified "2023-10-16" @default.
- W2030346704 title "Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience." @default.
- W2030346704 cites W1426844501 @default.
- W2030346704 cites W1520728869 @default.
- W2030346704 cites W1893740135 @default.
- W2030346704 cites W1954311312 @default.
- W2030346704 cites W1979300931 @default.
- W2030346704 cites W2047013318 @default.
- W2030346704 cites W2079050276 @default.
- W2030346704 cites W2113524784 @default.
- W2030346704 cites W2119211684 @default.
- W2030346704 cites W2167805334 @default.
- W2030346704 cites W2168812605 @default.
- W2030346704 cites W23441172 @default.
- W2030346704 cites W2395251040 @default.
- W2030346704 cites W2400584082 @default.
- W2030346704 cites W2417734794 @default.
- W2030346704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7490806" @default.
- W2030346704 hasPublicationYear "1996" @default.
- W2030346704 type Work @default.
- W2030346704 sameAs 2030346704 @default.
- W2030346704 citedByCount "4" @default.
- W2030346704 countsByYear W20303467042015 @default.
- W2030346704 countsByYear W20303467042020 @default.
- W2030346704 crossrefType "journal-article" @default.
- W2030346704 hasAuthorship W2030346704A5015263316 @default.
- W2030346704 hasAuthorship W2030346704A5025595895 @default.
- W2030346704 hasAuthorship W2030346704A5026192090 @default.
- W2030346704 hasAuthorship W2030346704A5042834618 @default.
- W2030346704 hasAuthorship W2030346704A5054874627 @default.
- W2030346704 hasAuthorship W2030346704A5072244858 @default.
- W2030346704 hasConcept C121608353 @default.
- W2030346704 hasConcept C126322002 @default.
- W2030346704 hasConcept C126894567 @default.
- W2030346704 hasConcept C141071460 @default.
- W2030346704 hasConcept C143998085 @default.
- W2030346704 hasConcept C2776694085 @default.
- W2030346704 hasConcept C2777132456 @default.
- W2030346704 hasConcept C2778065480 @default.
- W2030346704 hasConcept C2778239845 @default.
- W2030346704 hasConcept C2780352672 @default.
- W2030346704 hasConcept C2780873365 @default.
- W2030346704 hasConcept C2781059491 @default.
- W2030346704 hasConcept C71924100 @default.
- W2030346704 hasConcept C90924648 @default.
- W2030346704 hasConceptScore W2030346704C121608353 @default.
- W2030346704 hasConceptScore W2030346704C126322002 @default.
- W2030346704 hasConceptScore W2030346704C126894567 @default.
- W2030346704 hasConceptScore W2030346704C141071460 @default.
- W2030346704 hasConceptScore W2030346704C143998085 @default.
- W2030346704 hasConceptScore W2030346704C2776694085 @default.
- W2030346704 hasConceptScore W2030346704C2777132456 @default.
- W2030346704 hasConceptScore W2030346704C2778065480 @default.
- W2030346704 hasConceptScore W2030346704C2778239845 @default.
- W2030346704 hasConceptScore W2030346704C2780352672 @default.
- W2030346704 hasConceptScore W2030346704C2780873365 @default.
- W2030346704 hasConceptScore W2030346704C2781059491 @default.
- W2030346704 hasConceptScore W2030346704C71924100 @default.
- W2030346704 hasConceptScore W2030346704C90924648 @default.
- W2030346704 hasIssue "1" @default.
- W2030346704 hasLocation W20303467041 @default.
- W2030346704 hasOpenAccess W2030346704 @default.
- W2030346704 hasPrimaryLocation W20303467041 @default.
- W2030346704 hasRelatedWork W1964106203 @default.
- W2030346704 hasRelatedWork W2014930798 @default.
- W2030346704 hasRelatedWork W2030346704 @default.
- W2030346704 hasRelatedWork W2045948475 @default.
- W2030346704 hasRelatedWork W2088559719 @default.
- W2030346704 hasRelatedWork W2089471699 @default.
- W2030346704 hasRelatedWork W2343206312 @default.
- W2030346704 hasRelatedWork W2406863542 @default.
- W2030346704 hasRelatedWork W2424870840 @default.
- W2030346704 hasRelatedWork W4244013879 @default.
- W2030346704 hasVolume "155" @default.
- W2030346704 isParatext "false" @default.
- W2030346704 isRetracted "false" @default.
- W2030346704 magId "2030346704" @default.
- W2030346704 workType "article" @default.